GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,185 | -18.0% | 2,274 | 0.0% | 0.00% | – |
Q2 2021 | $2,664 | -13.6% | 2,274 | 0.0% | 0.00% | – |
Q1 2021 | $3,084 | +11.9% | 2,274 | 0.0% | 0.00% | – |
Q4 2020 | $2,755 | +5.7% | 2,274 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $2,607 | -0.4% | 2,274 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $2,618 | +33.7% | 2,274 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,958 | -16.9% | 2,274 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $2,356 | -28.6% | 2,274 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $3,300 | -26.0% | 2,274 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $4,461 | -16.9% | 2,274 | -87.5% | 0.00% | -33.3% |
Q1 2019 | $5,370 | +105.7% | 18,188 | 0.0% | 0.00% | +200.0% |
Q4 2018 | $2,611 | -63.2% | 18,188 | 0.0% | 0.00% | -75.0% |
Q3 2018 | $7,098 | -8.9% | 18,188 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $7,790 | -18.5% | 18,188 | 0.0% | 0.01% | -14.3% |
Q1 2018 | $9,559 | -9.5% | 18,188 | 0.0% | 0.01% | -22.2% |
Q4 2017 | $10,560 | -20.5% | 18,188 | 0.0% | 0.01% | -25.0% |
Q3 2017 | $13,290 | -72.0% | 18,188 | 0.0% | 0.01% | -72.7% |
Q2 2017 | $47,518 | -14.3% | 18,188 | 0.0% | 0.04% | -2.2% |
Q1 2017 | $55,437 | +149729.7% | 18,188 | +100.0% | 0.04% | +28.6% |
Q4 2016 | $37 | – | 9,094 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $10,276,000 | 10.63% |
NORTHPOINTE CAPITAL LLC | 1,336,062 | $6,974,000 | 0.73% |
AlphaMark Advisors, LLC | 304,886 | $1,592,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 490,000 | $2,558,000 | 0.44% |
Rock Springs Capital Management LP | 480,000 | $2,506,000 | 0.13% |
Birchview Capital, LP | 39,000 | $204,000 | 0.11% |
Artemis Wealth Advisors, LLC | 18,188 | $47,518 | 0.04% |
HAMILTON LANE ADVISORS LLC | 13,359 | $70,000 | 0.04% |
AXA S.A. | 586,066 | $3,059,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,000 | $788,000 | 0.01% |